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Abstract
Objective: To investigate the correlation of serum Vascular 
Endothelial Growth Factor (VEGF) levels and uterine fi broid 
volume.
Methods: Observational analytic study was carried out on 
80 patients with uterine fi broids indicated myomectomy. 
Each sample was examined for VEGF levels and volume of 
myoma tissue post myomectomy was measured by using 
Archimedes' law. Correlation test using the Spearman test.  
Results: A total of 80 samples of patients were examined for 
VEGF levels and uterine fi broids volume. The median VEGF 
is 360 pg/mL, the median uterine fi broids volume is 325 ml. 
The Spearman’stest shows p values (<0.01) and r (0.999).
Conclusions:  There is a signifi cant correlation between 
VEGF levels and uterine fi broids volume. The higher the 
VEGF level, the greater the volume of uterine fi broids.
Keywords: archimedes law, uterine fi broids volume,  VEGF.
Abstrak
Tujuan: Untuk mencari adanya korelasi antara kadar VEGF 
terhadap volume mioma uteri.
Metode: Penelitian ini berupa analitik observasional. 
Sampel yaitu pasien dengan mioma uteri yang diindikasikan 
tindakan miomektomi. Setiap sampel diperiksa kadar VEGF 
dan pascamiomektomi dilakukan pengukuran volume 
terhadap jaringan mioma dengan menggunakan hukum 
Archimedes. Uji korelasi menggunakan Spearman test.
Hasil: Sebanyak 80 sampel penderita mioma uteri diperiksa 
kadar VEGF kemudian dilakukan tindakan miomektomi. 
Median VEGF adalah 360 pg/mL, median volume uteri 
adalah 325 ml, uji korelasi Spearman didapatkan nilai p 
(<0,01) dan r (0,999).
Kesimpulan: Terdapat korelasi antara kadar VEGF dengan 
volume mioma uteri, semakin tinggi kadar VEGF maka 
semakin besar volume mioma uteri.
Kata kunci: hukum Archimedes, VEGF, volume mioma uteri.
INTRODUCTION
The knowledge of the mechanisms of growth 
of uterine fi broids has increased dramatically in 
recent years. Today, there are numerous potential 
directions for both the clinician and researcher 
to proceed when trying to attack these tumours 
medically.1 Each tumour appeared to have its 
own intrinsic growth rate. Tumour size has been 
related to variation in molecular markers, and it 
has been assumed that the molecular differences 
refl ect differences in tumour growth rates.2
In recent years tumour volume investigations 
have become a subject of increasing interest.3 
Estimating the size change of an organ is 
research and clinical assessment that is used to 
relate symptom development to organ growth, 
to identify treatment needs, and to evaluate 
treatment effectiveness.4
Vascular Endothelial Growth Factor (VEGF) 
is the trigger of angiogenesis. VEGF, also 
known as vascular permeability factor (VPF), 
is a multifunctional cytokine that increases 
microvascular permeability and directly 
stimulates endothelial cell growth and 
angiogenesis. Vascular endothelial growth factor 
(VEGF) is synthesized and secreted by various 
cultured tumour cells and tumours in humans.5 
These observations suggest that VEGF and other 
proangiogenic factors might be involved in the 
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development of uterine fi broids.6
Measurement of the uterine volume is very 
important in the follow-up of the treatment 
response. 7 A range of measurement techniques 
has been described which may be used to 
calculate uterine fi broid volume. 8 Archimedes 
principle can be used as a direct measurement 
of uterine fi broid volume.9 Archimedes' principle 
is one of the most essential laws of physics 
and fl uid mechanics. One of the applications of 
Archimedes' principle is in the measurement of 
the density of an irregularly shaped object.10
Further experimental studies are required 
in order to gain a better understanding of the 
growth factors that are involved in normal and 
pathological myometrial angiogenesis and to 
assess the potential of anti-angiogenic treatment 
strategies for uterine fi broids.11 Therefore, 
based on the theories that have been outlined, 
researchers want to see the correlation of serum 
levels of Vascular Endothelial Growth Factor 
(VEGF) with tumorigenesis of uterine myoma 
which is assessed through the volume of uterine 
myoma.
METHODS
This is an analytic study with a cross-sectional 
approach. This study aims to determine the 
correlation between serum Vascular Endothelial 
Growth Factor (VEGF) levels and the volume of 
uterine fi broids. This research was conducted in 
Obstetrics Gynecology Wards and the Operating 
Room of the General Hospital Dr. Zainoel 
Abidin (RSUZA) Banda Aceh from April 2019 
to September 2019. Laboratory tests for serum 
vascular endothelial growth factor (VEGF) levels 
were conducted at the Prodia Laboratory in 
Banda Aceh. Measurement of uterine fi broids 
volume was conducted in the Operating Room.  
Inclusion criteria include a diagnosis of uterine 
fi broids which was proven based on the results 
of anatomic pathology and patients underwent 
total myomectomy surgery. Exclusion criteria 
include tumour metastasis or suffering from 
other malignancies, pregnancy,  menopause, 
adenomyosis, and being on analogue Gn-RH 
therapy.
Blood specimens for the examination of VEGF 
levels were taken from median cubital vein. About 
3 ml was inserted into a serum separator tube 
and sent to the Banda Aceh Prodia Laboratory. 
The volume of uterine fi broids specimens from 
myomectomy was measured according to 
Archimedes' law. A 1000 ml measuring cup is 
fi lled with 0.9% NaCl liquid as much as 600 ml 
(recorded as V1). Cleaned uterine fi broid tissue 
is dipped into a measuring cup until the entire 
surface of the uterine fi broids is in the liquid. 
The increasing volume in the measuring cup is 
recorded as V2 in ml. Uterine fi broids volume is 
calculated by the formula V2-V1. Data analysis 
was performed using the Spearman test. Every 
numerical data will be tested for normality test.
RESULTS
There were 120 patient with a diagnosis of 
uterine fi broids in the period of  April 2019 to 
September 2019. A total of 29 were menopause, 2 
patients were accompanied by adenomyosis and 
the remaining 9 were pregnant so were excluded 
from this study. A total of 80 samples that fi t 
the criteria were conducted anamnesis, physical 
examination and additional examinations for 
analysis. All samples were given information and 
explanations regarding their participation in this 
study. Ethical eligibility was approved by the 
Health Research Ethics Committee at the Faculty 
of Medicine Universitas Syiah Kuala.
General characteristics assessed in this study 
were age, parity, location of uterine fi broids and 
patient complaints (Table 1). The independent 
variable is VEGF levels and the dependent variable 
is the volume of uterine fi broids.
Ages are grouped based on intervals per 10 
years ie 20-29 years, 30-39 years and 40-49 years. 
Most of the patients in this study were 40-49 
years as 67 (83.3%) patients. The mean age in this 
study was 41.73 ± 4.3 years with a minimum of 26 
years to a maximum of 49 years.
The multipara group is the highest frequency 
in this study as 62 (77.5%) samples. The mean 
parity in this study was 2.64 ± 1.15.
The most of location uterine fi broids in this 
study was intramural as 71 (88.8%) samples. 
The most symptoms that are complained is 
prolonged menstrual phase (only) as many as 52 
(65.0%) samples.
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The normality test on the VEGF variable 
shows an abnormal distribution with p-value 
0.000 (normally distributed if p> 0.05). After 
transforming the data using the Log10 function, 
the p-value obtained still shows that the data are 
not normally distributed (p = 0.002).
Normality test on variable of uterine fi broid 
volume shows an abnormal distribution with 
p-value < 0.001. After transforming the data using 
the Log10 function, the p-value obtained still 
shows that the data are not normally distributed 
(p = 0.002).
The central values and the spread values of the 
variable VEGF levels and uterine fi broids volume 
are presented in table 2. The table shows that the 
median VEGF levels in this study were 360 pg/
mL and the median uterine fi broids volume was 
325 ml.
The Spearman test showed that there was a 
signifi cant correlation between VEGF levels and 
uterine fi broid volume with p values <0.001. The 
r-value of 0.999 shows a positive and strong 
correlation between the two variables.
DISCUSSION
The prevalence varies, one of them based on 
the parity, age. Pathologically, the incidence of 
diagnosed fi broids amplifi es gradually with age. 
At 25-30 years the incidence is only 0.3 per 1000 
women-years, but by age 45-50 yearsold, the 
incidence has raised 20 fold. 9 The frequency of 
uterine fi broid cases in this study based on age, 
20-29 years was 2 (2.5%) samples, 30-39 years 
was 11 (13.8%) samples and peaked in the 40-49 
years was 67 (83.3% ) sample. These data indicate 
that uterine fi broids incidence is increasing by 
age. The increase in the age of group 40-49 years 
in this study reached 33-fold compared to the 
age group 20-29 years. 
Most studies conclude that parity is associated 
with the incidence of uterine fi broids. A woman 
who has given birth has a lower risk of developing 
uterine fi broids compared to nulliparous 
women.12 Parity was associated with a reduced 
risk of developing uterine fi broids. In a single-
centre study in Japan, the risk of uterine fi broids 
in women who had given birth three or more 
times was less than one-fi fth that of nulliparous 
women13 Although a direct protective effect 
of pregnancy has been demonstrated, little is 
known of the mechanism. There have been some 
suggestions that during postpartum uterine 
remodelling, there could be selective apoptosis 
of small lesions. Ischemia during parturition has 
also been proposed as a mechanism. Thus, it may 
be implied that fi broid tissue could be highly 
susceptible to ischemia during both parturition 
and remodelling.14
The highest incidence frequency of uterine 
fi broids in this study based on parity is the 
multipara. The increasing incidence of uterine 
fi broids in the multipara compared to nulliparous 
Because the data distribution of the two 
variables is not normal, the statistical analysis 
that can be used to analyze the hypothesis is the 
Spearman test. The results are presented in Table 
3 below.
Table 1. General Characteristic Table 3.  Analysis Results of Spearman’s Correlation Test
Table 2.  Median, Minimum and Maximum of VEGF Level 
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and primiparous was 8-fold and 31-fold, 
respectively. This result is different from previous 
studies. The researcher assumes that the sample 
in this study does not refl ect the population in 
our area so that there are possible differences in 
results with existing theories.
Uterine myomas have been classifi ed 
according to their general uterine position: 
submucous, intramural, and subserosal.15 
Intramural myomas are the most prevalent of all 
the leiomyomas. Two-dimensional transvaginal 
sonography detected a 58%–79% occurrence of 
intramural myomas among study populations 
with observable myomas.16 In a multicenter 
retrospective study involving two-dimensional 
transvaginal sonography, MRI, and LUS, intramural 
myomas comprised 58% of all myomas imaged, 
regardless of the imaging method used.15 Most 
of the locations of uterine fi broids in this study 
are intramurally followed by submucosal and 
subserosal.
Presenting symptoms play an important role 
in deciding the appropriate form of treatment 
for the affected woman. Management strategies 
are usually individualized based on the severity 
of the symptoms, the size and location of the 
fi broid, the patient’s age and their chronological 
proximity to menopause, and the patient’s desire 
for future fertility12
The majority of women with uterine fi broids 
are asymptomatic, and consequently get less 
clinical attention; fi broid tumours often remain 
undiagnosed. The most common presenting 
factor that symptomatic women typically complain 
about is abnormal uterine bleeding, specifi cally 
in terms of heavy and prolonged bleeding.12 The 
main complaint in this study is similar to existing 
epidemiological data. Prolonged menstrual phase 
complaints are the most common complaints in 
cases of uterine fi broids.
Correlation of VEGF Levels to Uterine 
Fibroids Volume
Theoretically, fi broid tumours generally grow 
slowly. In addition, the rate of growth of uterine 
fi broid in a patient also varies and some tumours 
will even spontaneously regress during growth. 
Therefore, it will be very diffi cult to predict 
the growth of uterine myomas or the onset of 
symptoms.2
Fibroid volume is one of important parameter 
for choosing the management options from no 
need any intervention as in small asymptomatic 
myomas, to surgical intervention in symptomatic 
one or cases of the large uterus with myomas 
comparable to or in surplus of 12-14 week 
pregnancy. Uterine fi broid volume is also 
necessary in follow up of cases under medical 
treatment (e.g Gn-RH analogues) to assess its 
success, while in cases of rapid growth planned 
for surgical intervention, myoma volume helps 
us to decide the incision type, site and length to 
diminish the surgical complications.9
Growth factors are involved in the pathogenesis 
of uterine fi broid by regulation of angiogenesis, 
which is necessary for the growth of uterine 
fi broid. Angiogenesis is a system that is controlled 
by proangiogenic and antiangiogenic factors.6, 
17One of the important factor in angiogenesis 
is vascular endothelial growth factor (VEGF). 
18 Several authors report that VEGF plays an 
important role in stimulating tumour growth.19 
VEGF has a mitogenic effect on endothelial cells 
that cause cell proliferation. VEGF also infl uences 
endothelial cell survival by inhibiting apoptosis.2
Spearman's correlation analysis in this study 
shows that there is a correlation between VEGF 
levels and the volume of uterine fi broids. The 
correlation between these two variables is very 
strong (r=0.999) with the direction of a positive 
correlation which means that the higher the 
level of VEGF, the greater the volume of myoma 
fi broids regardless of other factors that make 
biased.
VEGF is a potent proangiogenic factor 
and is an essential growth factor for vascular 
endothelial cells. The development of leiomyoma 
is associated with exposure to ovarian sex steroids 
and an increased requirement for vascular supply 
for their growth. These observations suggest that 
VEGF and other proangiogenic factors might be 
involved in the development of leiomyomas.6
The contribution of VEGF to tumour 
angiogenesis is well understood. VEGF is up-
regulated in many tumours and VEGF protein was 
detected in the culture media from a range of 
tumour cell lines. VEGF mRNA was also detected in 
numerous tumours and metastases, with immune 
reactivity for VEGF localized on tumour cells and 
in the stromal matrix. VEGF might be released 
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into the surrounding stromal matrix, which might 
contribute to tumour growth and metastasis in 
a paracrine manner through angiogenesis and 
increased vascular permeability. These fi ndings 
suggested VEGF may promote tumour growth by 
direct pro-survival effects in tumour cells.6
CONCLUSION
The median VEGF and median volume of uterine 
fi broids in this study were 360 pg/mL and 325 
ml, respectively. There is a signifi cant correlation 
between VEGF levels and uterine fi broids volume. 
The higher the VEGF level, the greater the volume 
of uterine fi broids.
SUGGESTION
Hopefully, this research can be continued to fi nd 
a VEGF cut off point to detect a beginning of 
progressive growth rate of uterine fi broids in a 
larger sample.
ACKNOWLEDGEMENT
The authors would like to give thank to Obstetrics 
and Gynecology Department of Faculty of 
Medicine in Universitas Syiah Kuala, Dr. Zaenal 
Abidin General Hospital Banda Aceh and Prodia 
Clinical Laboratory Banda Aceh for the help and 
collaborate on this research. This research do not 
have any confl ict of interest.
REFERENCES
Vol 8, No 2
April 2020 Serum Vascular Endothelial 111
